CTIS2023-506949-27-00进行中（未招募）1 期
Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease (RIGID)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- •Men and women aged 18-50 years
排除标准
- •Uncontrolled thyrotoxicosis, Allergy to prednisolone or one of the excipients, Systematic fungal infections, Vaccination with living or weaken viral or bacterial vaccines in patient who or immunocompromised. In these cases, prednisolone treatment should not be administered two weeks before and after vaccination., Not able to provide informed consent (e.g., dementia, not able to understand Danish). At the information meeting the investigator will make an individual assessment to evaluate whether a potential study participants understand the information., Chronic kidney disease (eGFR <30), Known Cushing’s syndrome, Previous gastric bypass and/or known ongoing malabsorption, Severe covid-19 in the last 3 month (defined as needing dexamethasone treatment), Use of oral or inhaled GCs within the past year, Menopause (defined as 1 year without menstrual bleeding), Pregnancy (defined as elevated HCG), Ongoing infection
研究者
相似试验
进行中（未招募）
2 期
Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone DiseaseOsteoporosis SecondaryNCT06421597Odense University Hospital36
进行中（未招募）
不适用
PRediction Of DIverse Glucocorticoids toxIcity OUtcomeSInflammatory RheumatismIdiopathic Inflammatory MyopathiesANCA Associated VasculitisSystemic Autoimmune DiseaseGiant Cell ArteritisPolymyalgia RheumaticaNCT04664465University Hospital, Brest300
已完成
不适用
Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism HypertensionCardiovascular DiseasesHeart DiseasesHypertensionNCT00005394National Heart, Lung, and Blood Institute (NHLBI)
已完成
4 期
Counteracting Deleterious Metabolic Glucocorticoid Effects With MetforminGlucocorticoid EffectNCT04659915Eleonora Seelig19
进行中（未招募）
1 期
Prevention of Glucocorticoid induced impairment of bone metabolism – A Randomized, Placebo-Controlled, Single Centre Clinical TrialOral glucocorticoid (GC) therapy leads to a rapid and profound effects on bone metabolism.The gut microbiota is involved in regulating bone metabolism.Lactobacillus reuteri (LR) has been shown to have probiotic, health-promoting effects.The aim of this randomized, double-blind, placebo-controlled trial is to investigate if daily supplementation with LR, compared to placebo, can prevent the negative effects of oral GC on bone turnover and on blood glucose regulation in healthy young adults.EUCTR2021-000275-36-SESahlgrenska University Hospital50